Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 5
2008 3
2010 3
2011 6
2012 5
2013 5
2014 13
2015 8
2016 5
2017 2
2018 4
2019 5
2020 7
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

63 results
Results by year
Filters applied: . Clear all
Page 1
Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31.
Chumsri S, Li Z, Serie DJ, Mashadi-Hossein A, Colon-Otero G, Song N, Pogue-Geile KL, Gavin PG, Paik S, Moreno-Aspitia A, Perez EA, Thompson EA. Chumsri S, et al. J Clin Oncol. 2019 Dec 10;37(35):3425-3435. doi: 10.1200/JCO.19.00443. Epub 2019 Oct 17. J Clin Oncol. 2019. PMID: 31622131 Free PMC article. Clinical Trial.
Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
Ross JS, Gay LM, Wang K, Ali SM, Chumsri S, Elvin JA, Bose R, Vergilio JA, Suh J, Yelensky R, Lipson D, Chmielecki J, Waintraub S, Leyland-Jones B, Miller VA, Stephens PJ. Ross JS, et al. Among authors: chumsri s. Cancer. 2016 Sep 1;122(17):2654-62. doi: 10.1002/cncr.30102. Epub 2016 Jun 10. Cancer. 2016. PMID: 27284958 Free article.
Carryover effects of aromatase inhibitors in prevention.
Chumsri S, Thompson EA. Chumsri S, et al. Lancet. 2020 Jan 11;395(10218):91-92. doi: 10.1016/S0140-6736(19)33102-2. Epub 2019 Dec 13. Lancet. 2020. PMID: 31843210 Free article. No abstract available.
63 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page